Moreover, effective evaluation of LysoPAF using the F211L variant may be useful for measuring Lp‐PLA2 activity during the assessment of cardiovascular and cerebrovascular disease risks. The gene discussed is PLA2G7; the disease is cerebrovascular disorder.